These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20231907)

  • 21. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inference using conditional logistic regression with missing covariates.
    Lipsitz SR; Parzen M; Ewell M
    Biometrics; 1998 Mar; 54(1):295-303. PubMed ID: 9544523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Score test for missing at random or not under logistic missingness models.
    Wang H; Lu Z; Liu Y
    Biometrics; 2023 Jun; 79(2):1268-1279. PubMed ID: 35348206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subgroup analysis with semiparametric models toward precision medicine.
    Yuan A; Chen X; Zhou Y; Tan MT
    Stat Med; 2018 May; 37(11):1830-1845. PubMed ID: 29575056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propensity score estimation with missing values using a multiple imputation missingness pattern (MIMP) approach.
    Qu Y; Lipkovich I
    Stat Med; 2009 Apr; 28(9):1402-14. PubMed ID: 19222021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of likelihood-based and marginal estimating equation methods for analysing repeated ordered categorical responses with missing data: application to an intervention trial of vitamin prophylaxis for oesophageal dysplasia.
    Mark SD; Gail MH
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):479-93. PubMed ID: 8023030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of tests for restricted orderings in the three-class case.
    Alonzo TA; Nakas CT; Yiannoutsos CT; Bucher S
    Stat Med; 2009 Mar; 28(7):1144-58. PubMed ID: 19156672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Approach to Testing for Average Bioequivalence Based on Modeling the Within-Period Dependence Structure.
    Chandrasekhar R; Shi Y; Hutson AD; Wilding GE
    J Biopharm Stat; 2015; 25(6):1320-38. PubMed ID: 25671781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of overall treatment effect in MMRM.
    Song T; Dong Q; Sankoh AJ; Molenberghs G
    J Biopharm Stat; 2013; 23(6):1281-93. PubMed ID: 24138432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of missing data on type 1 error rates in non-inferiority trials.
    Yoo B
    Pharm Stat; 2010; 9(2):87-99. PubMed ID: 19408241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model.
    Demissie S; LaValley MP; Horton NJ; Glynn RJ; Cupples LA
    Stat Med; 2003 Feb; 22(4):545-57. PubMed ID: 12590413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjusting for regression toward the mean when variables are normally distributed.
    Lin HM; Hughes MD
    Stat Methods Med Res; 1997 Jun; 6(2):129-46. PubMed ID: 9261912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the types of missingness in quality of life data from clinical trials.
    Curran D; Bacchi M; Schmitz SF; Molenberghs G; Sylvester RJ
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):739-56. PubMed ID: 9549820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
    Huang Y
    Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous growth bent-cable models for time-to-event and longitudinal data: application to AIDS studies.
    Dagne GA
    J Biopharm Stat; 2018; 28(6):1216-1230. PubMed ID: 29953318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized F test and generalized deviance test in two-way ANOVA models for randomized trials.
    Shen J; He X
    J Biopharm Stat; 2014; 24(3):523-34. PubMed ID: 24697334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The multiple benefits associated with HIV drug-resistance mutation M184V.
    Bean P
    Am Clin Lab; 2002 Mar; 21(2):16-8. PubMed ID: 11993249
    [No Abstract]   [Full Text] [Related]  

  • 39. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials.
    Mallinckrodt CH; Lin Q; Molenberghs M
    Pharm Stat; 2013; 12(1):1-6. PubMed ID: 23193075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response adaptive designs with a variance-penalized criterion.
    Yi Y; Wang X
    Biom J; 2009 Oct; 51(5):763-73. PubMed ID: 19757432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.